Antibacterial drugs, a subset of antimicrobials, are essential in the medical arsenal against bacterial infections. These drugs act through various mechanisms to inhibit bacterial growth, disrupt essential cellular processes, or outrightly kill the bacteria. Their versatility allows for the treatment of a wide range of bacterial infections, from common respiratory ailments to severe systemic diseases. In recent years, the field of antibacterial drug development has witnessed advancements in research and technology. Scientists are exploring novel targets and innovative approaches to counteract the rising threat of antibiotic resistance. Combination therapies, where multiple drugs are used simultaneously, are being explored as a strategy to enhance efficacy and minimize the development of resistance. The future of antibacterial drugs lies in a multidisciplinary approach, involving not only pharmaceutical research but also global collaboration to address issues of access, affordability, and responsible use. By staying at the forefront of scientific innovation and promoting a holistic approach, the medical community can continue to stay one step ahead of bacterial infections and safeguard public health.
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Pathogen-derived noncanonical epitopes: Are they valuable targets for novel vaccinations and shall we be concerned about autoimmune responses?
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : When acute EBV mimics HIV: A case of false positive p24 antigen and low-level HIV antibody reactivity
Smriti Chaudhary, Imperial College Healthcare NHS Trust, United Kingdom
Title : OnePeru: Peruvian bioinformatics platform to contribute to the fight against antimicrobial resistance
Pool Marcos Carbajal, University of San Martin de Porres, Peru
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain